Breakthrough research reveals how to target malignant DNA in aggressive cancers
Scientists have discovered a way to target elusive circular fragments of DNA that drive the survival of some of the ...
Tag: Small Cell Lung Cancer
Immunotherapy yields complete response in stage IV lung cancer
A new case report was published in Oncoscience (Volume 11) on October 8, 2024, entitled, "Complete and long-lasting response to immunotherapy in a ...
Immunotherapy timing key to survival in small cell lung cancer treatment
People with limited-stage small cell lung cancer may benefit from adding immunotherapy to chemoradiation, but not if both treatments are ...
AmoyDx® Pan Lung Cancer PCR Panel approved in Japan as a companion diagnostic for Haiyitan® tablets (gumarontinib)
Riken Genesis Co., Ltd., Amoy Diagnostics Co., Ltd., (“AmoyDx”) and Precision Medicine Asia Co., Ltd. (“PREMIA”) today announced that the ...
Novel combination treatment outperforms standard therapy in patients with EGFR NSCLC
The combination of the antibody amivantamab and lazertinib, a drug targeting EGFR, shows better clinical benefits compared to standard treatment ...
AI-based body composition analysis predicts lung cancer treatment outcomes
Tafadzwa Chaunzwa, MD, a researcher in the Artificial Intelligence in Medicine (AIM) Program at Mass General Brigham and a senior ...
Unveiling mechanisms of relapse in small cell lung cancer under therapy
Small cell lung cancer (SCLC) is a highly aggressive tumor of the lung that occurs especially in heavy smokers. Due ...
New understanding of lung cancer cells' 'memories' suggests novel treatment approach
A new understanding of lung cancer cells' "memories" suggests a new strategy for improving treatment, Memorial Sloan Kettering Cancer Center ...
Liquid biopsies could be used as an early marker of immunotherapy response, study finds
Liquid biopsies are blood tests that can serially measure circulating tumor DNA (cell-free DNA that is shed into the bloodstream ...
Drug combination can prolong survival and improve quality of life in patients with advanced lung cancer
A recent clinical trial showed that the drug combination of cemiplimab plus platinum chemotherapy can prolong survival in patients with ...
